Search by Drug Name or NDC
NDC 00517-0375-05 Indigo Carmine 8 mg/mL Details
Indigo Carmine 8 mg/mL
Indigo Carmine is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by American Regent, Inc.. The primary component is INDIGOTINDISULFONATE SODIUM.
Product Information
| NDC | 00517-0375 |
|---|---|
| Product ID | 0517-0375_354b6d2e-c8d2-4fc4-8505-914b64b34166 |
| Associated GPIs | 94200056002010 |
| GCN Sequence Number | 008260 |
| GCN Sequence Number Description | indigotindisulfonate sodium AMPUL 8 MG/ML INJECTION |
| HIC3 | R1U |
| HIC3 Description | RENAL FUNCTION DIAGNOSTICS AGENTS |
| GCN | 35190 |
| HICL Sequence Number | 003691 |
| HICL Sequence Number Description | INDIGOTINDISULFONATE SODIUM |
| Brand/Generic | Brand |
| Proprietary Name | Indigo Carmine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Indigo Carmine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 8 |
| Active Ingredient Units | mg/mL |
| Substance Name | INDIGOTINDISULFONATE SODIUM |
| Labeler Name | American Regent, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2022-12-31 |
Package
NDC 00517-0375-05 (00517037505)
| NDC Package Code | 0517-0375-05 |
|---|---|
| Billing NDC | 00517037505 |
| Package | 5 AMPULE in 1 BOX (0517-0375-05) / 1 mL in 1 AMPULE (0517-0375-01) |
| Marketing Start Date | 1990-09-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |